INFLUX

Influx Healthtech Share Price

 

Stock Hit Upper Circuit

 

Start SIP in INFLUX

Start SIP

Performance

  • Low
  • ₹191
  • High
  • ₹198
  • 52 Week Low
  • ₹120
  • 52 Week High
  • ₹208
  • Open Price₹196
  • Previous Close₹189
  • Volume181,200

Investment Returns

  • Over 1 Month + 17.19%
  • Over 3 Month + 37.15%
  • Over 6 Month + 106.3%
  • Over 1 Year + 106.3%

Smart Investing Starts Here Start SIP with Influx Healthtech for Steady Growth!

Invest Now

Influx Healthtech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 34.3
  • PEG Ratio
  • -
  • Market Cap Cr
  • 459
  • P/B Ratio
  • 11.1
  • Average True Range
  • 10.01
  • EPS
  • 5.77
  • Dividend Yield
  • 0
  • MACD Signal
  • 2.68
  • RSI
  • 55.93
  • MFI
  • 56.06

Influx Healthtech Financials

Influx Healthtech Technicals

EMA & SMA

Current Price
₹198.05
+ 9.4 (4.98%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 11
  • 20 Day
  • ₹183.05
  • 50 Day
  • ₹177.21
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

182.68 Pivot Speed
  • R3 212.52
  • R2 200.58
  • R1 194.62
  • S1 176.72
  • S2 164.78
  • S3 158.82

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Influx manufactures nutraceuticals, cosmetics, herbal, veterinary, and homecare products across certified plants., offering contract manufacturing of tablets, capsules, gummies, powders, protein bars, and creams at competitive rates.

Influx Healthtech Ltd has an operating revenue of Rs. 340.08 Cr. on a trailing 12-month basis. An annual revenue growth of 5% is not great, Pre-tax margin of 17% is great, ROE of 36% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 6% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 9% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 45 which is a POOR score indicating inconsistency in earnings, a RS Rating of 89 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 49 indicates it belongs to a fair industry group of Medical-Supplies and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Influx Healthtech Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-12 Quarterly Results

Influx Healthtech F&O

Influx Healthtech Shareholding Pattern

73.53%
0.07%
1.84%
0%
13.92%
10.64%

About Influx Healthtech

  • NSE Symbol
  • INFLUX
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Munir Abdul Ganee Chandniwala
  • ISIN
  • INE0MYZ01012

Similar Stocks to Influx Healthtech

Influx Healthtech FAQs

Influx Healthtech share price is ₹198 As on 13 November, 2025 | 13:24

The Market Cap of Influx Healthtech is ₹458.5 Cr As on 13 November, 2025 | 13:24

The P/E ratio of Influx Healthtech is 34.3 As on 13 November, 2025 | 13:24

The PB ratio of Influx Healthtech is 11.1 As on 13 November, 2025 | 13:24

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23